Fig. 5.
A comparison of sympathetic ABR gains (A–C) and cardiac ABR gains (D–F) derived during the modified Oxford trials between normotensive (NTN-T2D) and hypertensive type 2 diabetes patients (HTN-T2D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.